Obesity still implies health hazards on human presented in actual increment on respiratory complaints and subsequent pulmonary derangement. Objective This study aimed to evaluate the effect of obesity on bronchial airway hyperresponsiveness and on the inflammatory markers of the airways.
Introduction
Airway hyper-reactivity (AHR) is defined as an exaggerated airway response to different confounders that leads to a higher risk of obstruction of the airway. These confounders may be physical confounders such as cold air or chemical confounders such as adenosine monophosphate, histamine, or sulfur dioxide. AHR is a sign of a decline in the pulmonary function and is a risk factor for the development of asthma symptoms in children and adults. It may be an alarm for the need to start pharmacological therapy for this airway hyperresponsiveness [1] .
AHR can also be defined as increased responsiveness of the airways to inhaled confounders that leads to an obstructive response of the airway, even when spirometric results are normal. AHR is commonly evaluated by using direct challenge tests or indirect challenge tests (according to the degree and extent of affection of the precipitating factor and relation to smooth-muscle contraction) [2] .
Obesity is a multifactorial disease that leads to a wide diversity of medical problems. In 1998, the WHO considered obesity a global epidemic [3] . In 2005, in a research carried out by Fantuzzi [4] , who assessed the inflammatory markers in obese patients, it was found that fractional exhaled nitric oxide (FeNO) level, interleukin-6, and C-reactive protein (CRP) are significantly increased in obese patients compared with normal individuals. Several studies have also hypothesized a possible relationship between the increased BMI, as an index of obesity, and hypersensitivity disorders such as bronchial asthma [5] [6] [7] . In 2005, Weiss [8] 
had suggested a common pathway for inflammation between obesity and hypersensitivity disorders that could explain the association between obesity and hyperactive airway
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development. The adipose tissue is an active secretory tissue that sends out signals that play a role in modulating inflammatory and immunological responses of the body to different confounders and stimuli [9] . Moreover, adipose tissue enhances different chemical modulators such as leptin and adiponectin that synergize to magnify the inflammatory response of the body to different confounders. This observation may provide an explanation for the association between obesity and hypersensitivity disorders [10] . Moreover, obesity has a direct effect on the performance of lung expansion and respiratory muscle strength [11] [12] [13] .
Through the previously mentioned mechanisms, obesity could affect the respiratory system and cause different symptoms such as breathlessness, recurrent paroxysms of cough, or wheezes [14] . Obesity also affects the functional residual capacity (FRC), which could be decreased less than normal [15] , and may even cause alterations in different lung volumes [16, 17] . The effects of obesity on the severity of asthma and degree of control of attacks of asthma could be explained by various mechanisms: changes in the performance of lungs' expansion [18] , alteration in inflammatory mediators [19] , unresponsiveness to steroid therapy [20] , and the presence of other comorbid diseases and the effect of their medications in aggravating hypersensitivity or causing interaction with the asthma medications [21] .
Therefore, this study was carried out to evaluate the effect of obesity on airway hyper-responsiveness and the inflammatory markers of the airways.
Participants and methods
This study was carried out at the Chest Medicine Department, Mansoura University Hospital, in collaboration with Mansoura University Children Hospital, Egypt, in the period from October 2015 to October 2017 after approval of the Local Ethical Committee of Faculty of Medicine, Mansoura University, was obtained. This study included 98 nonasthmatic cases, 46 individuals with normal BMI (group A) and 52 overweight and obese individuals with BMI more than 24.9 (group B), ranging in age from 14 to 59 years. The following individuals were excluded from the study: asthmatic patients, smokers, patients with organ failure, pregnant females, patients with systemic inflammatory disorders (such as collagen vascular diseases), patients with symptoms or signs of recent infection, and patients with malignant neoplasms.
Cases or their relatives delivered signed written consents after providing a detailed explanation of the protocol of the study.
All cases were subjected to the following: (I) assessment of history and clinical examination, (II) Spirometry (smart PFT lab; Medical Equipment Europe GmbH, Hammelburg, Germany) according to the standardized protocol, (III) Bronchial challenge with hypertonic saline (4.5%); (IV) Measurement of FeNO to evaluate airway inflammation, and V] Measurement of serum levels of high-sensitivity C-reactive protein (hs-CRP) using the enzyme-linked immunosorbent assay method by Immunospec Corporation Kits (7018 Owensmouth Ave, Canoga Park, CA, USA) ( Figure 1 ).
Bronchial challenge test with a hypertonic saline solution
(1) The bronchial challenge test with hypertonic saline solution was performed using the techniques of Smith and Anderson [22] , which have been adopted by the European Respiratory Society. (2) Cases were exposed to 2.5 ml of hypertonic saline (3) After a total dose of 15 ml of application. (4) Cases were observed for 20 min following the test. (5) The test was considered positive if the final FEV 1 (following the 8 min exposure or following cessation of the test) was 15% below the baseline. (6) Those in whom decreases in FEV 1 greater than 15% were recorded were administered an inhaled bronchodilator (salbutamol 5 mg) through a nebulizer or 200 μg through an inhaler and observed until FEV 1 improved to within 10% of the baseline value.
Fractional exhaled nitric oxide measurements [23] These measurements were performed using a handheld NO breath device, manufactured by Bedfont Scientific Ltd (Station Rd, Harrietsham, Maidstone ME17 1JA, UK).
Interpretation of FeNO levels was performed according to ATS 2011 guidelines as follows:
(1) FeNO less than 25 ppb: low (normal) (<20 ppb in children). The normality of data was first tested using a onesample Kolmogorov-Smirnov test. Qualitative data were described using number and percent. The association between categorical variables was tested using the χ 2 -test. Continuous variables were presented as mean±SD for parametric data and median for nonparametric data. The two groups were compared using the Student t-test (parametric data) and the Mann-Whitney test (nonparametric data). Spearman correlation was used to correlate nonparametric data. For all the above-mentioned statistical tests performed, the threshold of significance was fixed at the 5% level (P value).
Results
This table shows that the age range is comparable for the two groups (Table 1 ). In group A, there is no sex predilection, whereas in group B, there are significantly more females than males. The mean BMI for groups A, B were 22.79 and 34.76, respectively, with a highly significant statistical difference ( Table 2) . This table shows statistically significant differences between groups A and B in spirometric measurements of pulmonary function apart from forced expiatory flow 25 to 75% (Table 3 ).
This table shows the predominance of bronchial hyperreactivity in group B with a statistically significant difference between groups A and B (Table 4).
This table shows that FeNO was significantly higher in normal BMI cases than overweight and obese cases, in contrast to hs-CRP, which was significantly higher in group B than group A ( Table 5 ).
This table shows a significant positive correlation between BMI and hs-CRP level, whereas for the FeNO level with BMI, there is a significant negative correlation.
Discussion
Nowadays, obesity is being reflected as an overwhelming risky medical dilemma, that can derange health in many issues. A rising mass of review of literature have emphasized a strong link between obesity as a disease and bronchial hyperreactivity. In this study, bronchial hyper-reactivity testing with hypertonic saline 4.5% was significantly higher in overweight and obese cases (group B) in comparison with those with normal BMI (group A).
In truth, some authors found a relation between higher BMI and a higher PC20 [provocation concentration] [24] . Also, Huang et al. [25] noted that there was a low predominance of AHR in the lowermost quintile in teenage girls in their BMI. Another study observed that higher BMI was also linked to higher bronchial reactivity in school-age boys [26] . Moreover, debatable data have been recognized on the potential hazards of higher BMI on pulmonary function measurement; some authors found a reduction in FEV 1 , FVC, and FEV 1 /FVC with increase body gain [27] , whereas the reverse was detected by other groups of authors [28] [29] [30] .
In remark, studies that were carried out on asthmatic patients showed that bronchial asthma symptoms and their level of control improved after weight reduction in obese asthmatics [31, 32] . Increased BMI was related strongly to asthma worsening and greater severity with poor control [33, 34] . Our research did not include asthmatic patients; hence, we cannot confirm or deny this piece of information but we can refer to. In terms of handling spirometry, normal BMI cases showed better functional parameters compared with obese cases, clearly indicating the major negative impact of obesity on the functional behavior of the respiratory system.
In our study we used FeNO as a marker of airway inflammation. Nitric oxide is produced when the amino acid l-arginine is broken by enzyme nitric oxide synthases (NOS) into the amino acid lcitrulline. Three known isoforms of NOS are present, but singularly, inducible NOS looks like to play a role in the increased levels of NO in the exhaled breath of asthma individual. The enzymatic expression is upregulated by a varied range of inflammatory cytokines. Although indefinite cells are responsible for the increased NO production, airway epithelial cells and eosinophil's are considered to be the most important nominees [35] . Inflamed airways have been documented to produce increased levels of NO. High FeNO is considered to be a substitute inflammatory marker of long-term eosinophilic airway inflammation, and may reflect the prevalence of uncontrolled asthma and cause future asthma exacerbations [36] . News and records on the link between FeNO and treatment response remain inconsistent [37] .
In this study, FeNO levels were lower in obese patients compared with those with normal BMI. This low NO production in the airways of obese patients was tested by Holguin and colleagues. Obesity was linked to the lack of balance between l-arginine (a precursor of NO production by iNOS) and asymmetric dimethyl arginine (ADMA) (an endogenous inhibitor of all NOS) [38] . High levels of ADMA are known to be strongly linked to obesity as well as metabolic syndrome [39] . As a result of low levels of larginine/ADMA ratios, obese patients with asthma produce less NO. Another explanation for the low NO production is that airway inflammation mediated in obese asthmatics is neutrophilic to some extent more than eosinophilic type [40] .
On laboratory field, serum hs-CRP is considered to be an indicator of systemic inflammation. Scott and colleagues examined induced sputum and venous blood samples for the presence of inflammatory markers in 194 individuals (obese and nonobese asthmatics, in addition to obese and nonobese healthy controls). CRP showed a significant increase in obese compared with nonobese individuals, with a substantial interaction between obesity and asthma on CRP, such that the presence of asthma led to higher CRP levels so CRP presented a higher significance in obese asthmatics compared with obese control cases [41] . These data indicate that severe airway inflammation in obese individuals with positive BHR adds to the low-grade systemic inflammation already present in obese individuals. A large study (population-based cohort) carried out on 1000 individuals to show the relations of hs-CRP with spirometric lung function concluded that higher levels of CRP are linked to a subsequent decrease in lung function irrespective of BMI or asthma [42] . Similarly, in this study, hs-CRP showed higher titer in group B than group A and statistically significant differences were found. Many limitations in this study have been enlisted, form these the need to another airway marker to investigate the screened cases, the need for multicenter surveys for detailed analysis also grading of obesity and classifying obesity into android and gynecoid types and lastly hormonal assay in obese asthmatic cases.
Conclusion
Obesity continues to threaten health more and more, as long as no prophylaxis is tried. It is associated with more airway hyper-responsiveness, lower lung volumes, lower FeNO levels, and a low grade of systemic inflammation.
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